Halozyme Therapeutics, Inc. (HALO)
71.29
-0.42
(-0.59%)
USD |
NASDAQ |
Jan 22, 15:26
Halozyme Therapeutics Price: 71.29 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 219.25 |
| Merck & Co., Inc. | 109.34 |
| AIM ImmunoTech, Inc. | 1.26 |
| Stryker Corp. | 359.48 |
| Skye Bioscience, Inc. | 1.06 |
Price Related Metrics
| PE Ratio | 14.99 |
| PS Ratio | 7.200 |
| PEG Ratio | 0.2610 |
| Price to Book Value | 16.64 |
| Price to Free Cash Flow | 14.86 |
| Earnings Yield | 6.67% |
| Market Cap | 8.383B |
| PEGY Ratio | 0.2610 |
| Operating PE Ratio | 12.14 |
| Normalized PE Ratio | 14.99 |